CARMAT (EPA:ALCAR) | Finanzwire

Basculer en Français

8296	Companies
114905	Keywords
55332	Articles
62461	Press releases

Home
Companies
CARMAT

PRESS RELEASE

published on 09/18/2024 at 07:14, 2 months 3 days ago

Inside Information / Operations of the issuer (acquisitions, sales...)
CARMAT launches a capital increase of €10.3 million, extendable up to €13.6 million, with a subscription price of €1.60 per share to fund activities until at least 2024. Offering includes priority period for shareholders and global placement

Financial Structure Capital Increase Subscription Price CARMAT Global Placement
PRESS RELEASE

published on 09/06/2024 at 07:00, 2 months 15 days ago

Inside Information / News release on accounts, results
CARMAT announces its 2024 half-year results, including €3.3M in sales, 20 Aeson® artificial heart implants, and reduction in cash-burn. The company also plans to achieve annual sales of €8-12M in 2024 and explores financing options

Sales Financing CARMAT 2024 Results Aeson Heart
PRESS RELEASE

published on 09/06/2024 at 07:00, 2 months 15 days ago

Half yearly financial reports and audit reports/limited reviews / Half yearly financial report
BRIEF

published on 09/03/2024 at 19:49, 2 months 17 days ago

Status of voting rights and capital of the company CARMAT

Share Capital Voting Rights Equitization CARMAT Actions PACEO Financing
BRIEF

published on 08/21/2024 at 18:05, 2 months 30 days ago

Modification of the Rights Attached to the Categories of CARMAT Shares

Share Capital Funding Action Right To Vote CARMAT
BRIEF

published on 07/09/2024 at 07:05, 4 months 12 days ago

CARMAT boosts its sales and affirms its development

Business Development CARMAT Aeson® Locations EFICAS Study
PRESS RELEASE

published on 07/09/2024 at 07:00, 4 months 12 days ago

Inside Information / Other news releases
CARMAT exceeds 2023 sales, with €3.2M revenue in H1 2024 & 20 Aeson® heart implants. Confidence in growth outlook maintained. EFICAS study progressing well

Financial Results Sales Momentum CARMAT EFICAS Study Aeson Heart Implants
BRIEF

published on 07/08/2024 at 07:05, 4 months 13 days ago

CARMAT to Provide Half-Year Update on July 9, 2024

Financial Update CARMAT Artificial Heart Videoconference
PRESS RELEASE

published on 07/08/2024 at 07:00, 4 months 13 days ago

Inside Information / Other news releases
CARMAT to provide a half-year update and host a videoconference in French on July 9, 2024. The update will cover advancements of the Aeson artificial heart and key company developments

CARMAT Aeson Artificial Heart Videoconference Half-year Update Therapeutic Alternative
BRIEF

published on 06/25/2024 at 07:05, 4 months 26 days ago

New governance at CARMAT

Governance Nomination Heart Failure CARMAT Pierre Bastid

Accesswire

Published on 11/21/2024 at 13:30, 28 minutes ago

AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 28 minutes ago

Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 58 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 58 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 58 minutes ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 13:15, 43 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 23 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 43 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 1 hour 52 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 1 hour 58 minutes ago

Holding(s) in Company

Les Echos

Published on 11/21/2024 at 06:58, 7 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 38 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 13 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 13 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE